Literature DB >> 11529628

Malignancy in Behçet's disease: a report of 13 cases and a review of the literature.

M Cengiz1, M K Altundag, A F Zorlu, I H Güllü, E Ozyar, I L Atahan.   

Abstract

Behçet's disease (BD) has rarely been reported in association with malignant diseases. In most cases the autoimmune nature of the disease itself or immunosuppressive drug use has been blamed for malignant transformation. We report 13 cases of BD concurrent with neoplastic disease as well as treatment-related morbidities in this particular patient group. Between 1986 and 1999, 400 patients were diagnosed as having BD in Hacettepe University Hospitals. Of these 13 patients, 3.25% developed malignant diseases within a median follow-up time of 9.8 years. Solid tumors were diagnosed in 10 patients and haematological or lymphoid malignancies in three. Surgery was performed in seven patients, whereas radiotherapy was applied in six and chemotherapy in eight. A literature review revealed 27 cases of BD associated with malignancies, mostly lymphoid or haematological. Ten of our cases were solid tumors, and to our knowledge most of these are the first reported cases of specific malignancies concurrent with BD. Treatment-related morbidities were wound infection as surgical morbidity in one patient (1/7) and radiotherapy-related morbidity in three (3/6) patients in a median follow-up time of 2 years. Solid tumors in addition to lymphoid and haematological malignancies are also seen during the course of BD. Radiation therapy may cause severe late toxicities in the presence of BD. Chemotherapy and surgery are fairly safe for the treatment of malignancies in BD patients.

Entities:  

Mesh:

Year:  2001        PMID: 11529628     DOI: 10.1007/s100670170036

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

Review 1.  Behçet's disease and comorbidity: internal case reports and literature review.

Authors:  Zemfira Alekberova; Vadim Gorodetskiy; Fatima Izmailova; Stefka Radenska-Lopovok; Elnura Talybova; Margarita Evsikova; Nikolai Timoshin; Evgeni Nasonov
Journal:  Rheumatol Int       Date:  2015-02-13       Impact factor: 2.631

Review 2.  Cytotoxic T-cell lymphoma arising in Behçet disease.

Authors:  Yukitaka Katsura; Kazumi Suzukawa; Hiroshi Kojima; Chikashi Yoshida; Seiichi Shimizu; Harumi Mukai; Yuichi Hasegawa; Shigehiko Imagawa; Naoyoshi Mori; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

3.  Behcet's disease associated with malignancy in Korea: a single center experience.

Authors:  Joong Kyong Ahn; Ji Min Oh; Jaejoon Lee; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Rheumatol Int       Date:  2009-12-17       Impact factor: 2.631

4.  Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from Colombia.

Authors:  Paúl Alejandro Méndez Patarroyo; José Félix Restrepo; Samanda Adriana Rojas; Federico Rondón; Eric L Matteson; Antonio Iglesias-Gamarra
Journal:  J Autoimmune Dis       Date:  2009-02-27

5.  Role of polymorphisms in Adamantiades-Behçet's disease.

Authors:  Virginia G Kaklamani; Maureen Sadim; Yvoni Koumantaki; Phedon Kaklamanis; Boris Pasche
Journal:  J Rheumatol       Date:  2008-10-15       Impact factor: 4.666

6.  High Incidence of Gastrointestinal Ulceration and Cytogenetic Aberration of Trisomy 8 as Typical Features of Behçet's Disease Associated with Myelodysplastic Syndrome: A Series of 16 Consecutive Chinese Patients from the Shanghai Behçet's Disease Database and Comparison with the Literature.

Authors:  Yan Shen; Hai-Fen Ma; Dan Luo; Jian-Fei Cai; Jun Zou; Jian-Long Guan
Journal:  Biomed Res Int       Date:  2018-04-24       Impact factor: 3.411

7.  Morbidity of solid cancer in Behςet's disease: analysis of 11 cases in a series of 506 patients.

Authors:  So Young Na; Jaeyoung Shin; Eun-So Lee
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

8.  Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?

Authors:  William B Yates; Peter J McCluskey; Denis Wakefield
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.